Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Receivables - Other (2010 - 2011)

Updated

Tg Therapeutics (TGTX) recorded Receivables - Other of $244,479 in Q4 2010.

Analysis

Tg Therapeutics (TGTX) Receivables - Other (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 244,479.00
Dec 31, 2010 244,479.00
API Access

Tg Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TGTX&period=max&api_key=YOUR_API_KEY